Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 2416 AL 2430

Mitochondrial Dysfunction as a Driver of Neurodegeneration in Parkinson's and Huntington's Disease: Molecular Insights and Emerging Interventions

Kuwar OK, Khan S, Maloo A, Singh C, Sharma M, Maparu K, Dhingra MS, Sharma V.

Mol Neurobiol. 2026 Jun 10;63(1):685. doi: 10.1007/s12035-026-05991-w.

Bilateral Striatal Hypometabolism on FDG PET in a Patient With McLeod Syndrome

Xu D, Wang Y, Li Q, Wang L.

Clin Nucl Med. 2026 Sep 1;51(9):861-862. doi: 10.1097/RLU.0000000000006561. Epub 2026 Jun 9.

Naringenin as a multi-target neuroprotective agent in neurodegenerative diseases

Gurung N, Choi DY, Park PH.

Neurochem Int. 2026 Sep;198:106203. doi: 10.1016/j.neuint.2026.106203. Epub 2026 Jun 11.

Development and validation of the first needs-based quality of life measure for individuals with manifest Huntington's disease

Spray I, Grzeda MT, Thorpe J, Johnstone E, Hannemann W, Squitieri F, Giancaterino G, Mina PE, D'Alessio B, Arnesen A, Klempíř J, Ulmanová O, van Lonkhuizen P, Heemskerk AW, Hoblyn J, O'Malley E, Moldovan R, Landwehrmeyer GB, McKenna SP, Mühlbäck A; HEALTHE-RND consortium.

J Neurol. 2026 Jun 11;273(7):391. doi: 10.1007/s00415-026-13898-8.

Histological and Tissue-Level Outcomes of Stem Cell Therapies in Neurodegenerative Disorders: A Systematic Review

Fikry H, Saleh LA, Sadek DR.

Clin Anat. 2026 Jun 12. doi: 10.1002/ca.70147. Online ahead of print.

Focused ultrasound-mediated nanocarrier delivery across the blood-brain barrier for neurodegenerative diseases

Jaberi KR, Haghighi MR, Aligholi H, Takallu S, Asadi P, Mirzaei E, Jaberi AR, Sahraian A.

Biomed Pharmacother. 2026 Aug;201:119622. doi: 10.1016/j.biopha.2026.119622. Epub 2026 Jun 13.

Olfactory impairment in Huntington's disease: A systematic review and meta-analysis

Di Cesare F, Di Carlo C, Di Cesare L, Kottner J, Zaragoza-Domingo S, Schreiber R.

Neurosci Appl. 2026 Jun 1;5:107016. doi: 10.1016/j.nsa.2026.107016. eCollection 2026.

Modeling striatal development and disease with human pluripotent stem cells

Supakul S, Sasaki Y, Karasawa K, Kase Y, Ishikawa M, Okano H.

Inflamm Regen. 2026 Jun 15;46(1):32. doi: 10.1186/s41232-026-00428-2.

Menopause in rare diseases: Shared research concerns and the case for a dedicated subfield

Sufian S.

Maturitas. 2026 Aug;211:109011. doi: 10.1016/j.maturitas.2026.109011. Epub 2026 Jun 4.

GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation

Li P, Gao Y, Liu W.

Drug Des Devel Ther. 2026 Jun 12;20:613616. doi: 10.2147/DDDT.S613616. eCollection 2026.

Exercise-Driven NRF2 Activation as a Systemic Neuroprotective Strategy: Integrating Redox Biology, Muscle-Brain Crosstalk, and Therapeutic Targeting in Neurodegeneration

Deng P, Deng W, Wang L, Ye W, Li S.

Biochem Genet. 2026 Jun 18. doi: 10.1007/s10528-026-11415-0. Online ahead of print.

Microglia-driven neuroinflammatory signaling in neurodegeneration: mechanisms and therapeutic opportunities

Saini K, Dhiman P.

Mol Biol Rep. 2026 Jun 18;53(1):941. doi: 10.1007/s11033-026-12128-8.

Hyperglycemic chorea: clinical insights and a narrative review of case reports

Singh A, Agrawal R, Khaliq W.

Postgrad Med. 2026 Aug;138(6):676-686. doi: 10.1080/00325481.2026.2690294. Epub 2026 Jun 18.

Assessment of Dose Proportionality and the Effect of Food on a Once-Daily Extended-Release Tablet Formulation of Deutetrabenazine in Healthy Participants

Sunzel EM, Ghibellini G, Gutierrez M, Ruffo D, Chavan S, Birajdar NG, Schneider F, Loupe P, Gordon MF, Rabinovich-Guilatt L.

Clin Drug Investig. 2026 Aug;46(8):911-923. doi: 10.1007/s40261-026-01566-8. Epub 2026 Jun 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias